Delivery Order SPE2DB22D1106-SPE2DB24FFBV8

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $6,926.39 and a completion date of November 19, 2024. It is a firm fixed-price delivery order contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
This federal contract award, with a ceiling value of $1,070.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product, with a period of performance ending on December 24, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing mechanism. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $1,539.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
The federal contract award, with ID SPE2DB22D1200|SPE2DB24FN3TS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4565178393 BRILINTA 60 MG TABLET 60S. This is a firm fixed-price delivery order contract with a ceiling value of $1,638.36 and an ultimate completion date of July 18, 2024. The contract is not set aside. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF2DH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.06 firm fixed-price delivery order contract is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is associated with a larger...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FT29H, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BRILINTA 60 MG TABLET 60S. The contract has a total ceiling value of $1,213.62 and is a Firm Fixed Price Delivery Order type contract, with a period of performance ending on March 28, 2024. The contract was awarded on March 27, 2024, and does not have a set-aside designation. AmerisourceBergen...
This federal contract award, valued at $2,895.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of February 27, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating...
This federal contract award, identified as SPE2DB22D1017|SPE2DB25FF4UX, was granted by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of February 6, 2025 and a ceiling value of $1,382.48. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation. Amerisourcebergen...
This federal contract award, with the ID SPE2DB24D2003|SPE2DB25FXEH0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,079.86 contract is a firm fixed-price delivery order for the supply of BRILINTA 60 MG TABLET 60S, a cardiovascular medication. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award, with an ID of SPE2DB20D1004|SPE2DB24FG0K1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $2,544.29 and is a Firm Fixed Price Delivery Order, with a completion date of May 16, 2024. This contract award is not designated as a set-aside and...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFBV8
    Delivery Order

This federal contract award, identified as SPE2DB22D1106|SPE2DB24FFBV8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $1,282.01 and is a Firm Fixed Price Delivery Order, with a completion date of July 15, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:13 AM